MedPath

Effect of Tranexamic ????Acid on treatment of Epidural Hematoma

Phase 2
Completed
Conditions
Epidural Hematoma.
Epidural haemorrhage
Registration Number
IRCT2014040915657N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Head trauma; GCS=15; Epidural hematoma with maximum diameter of 1 cm; Age 18-75 years old; Informed consent to participate in research

Exclusion criteria: GCS less than or equal to 13; Require surgery to evacuate the hematoma; History of anticoagulation therapy; History of head trauma; Occipital hematoma; Multiple trauma; Mid line shift; History of internal disease; age under 18 and older than 75 years old; During lactation and pregnancy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Maintain or reduce of Epidural Hematoma diameter after intervention. Timepoint: Before intervention and 48 hours after intervention. Method of measurement: Brain CT Scan and measurment of the maximum diameter of the Epidural Hematoma with Millimetrs.;The rate of change of level of consciousness. Timepoint: At admission and 48 hours after intervention. Method of measurement: Glasgow Coma Score (GCS).;The approximate volume of epidural hematoma. Timepoint: At admission and 48 hours after intervention. Method of measurement: Brain CT Scan and measurment of the maximum volume of the Epidural Hematoma with Milliliters.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath